The American Film Institute (AFI) has announced that the world premiere of Clint Eastwood’s Juror #2 will close the 38th edition of AFI Fest. The Warner Bros. Pictures film stars Nicholas Hoult, Toni Collette, J.K. Simmons, Chris Messina, Gabriel Basso, Zoey Deutch, Cedric Yarbrough, Leslie Bibb and Kiefer Sutherland. Juror #2 will screen as the AFI Fest Closing Night Red Carpet Premiere at the historic TCL Chinese Theatre on October 27.
“There is only one Clint Eastwood–and AFI is proud to present the world premiere of this next chapter in his historic canon,” said Bob Gazzale, AFI president and CEO. “We are honored to bring the community together once again–artists and audiences–to celebrate an American icon.”
The premiere of Juror #2 continues a long relationship between Eastwood and AFI. Eastwood launched the World Premieres of American Sniper, J. Edgar and Richard Jewell at AFI Fest. In 1996, Eastwood received the 24th AFI Life Achievement Award–the highest honor for a career in film, and in 2009, AFI conferred an Honorary Degree upon Eastwood for contributions of distinction to the art of the moving image.
Juror #2 follows family man Justin Kemp who, while serving as a juror in a high profile murder trial, finds himself struggling with a serious moral dilemma…one he could use to sway the jury verdict and potentially convict–or free-–the accused killer.
Juror #2 is written by Jonathan Abrams; produced by Eastwood, Tim Moore, p.g.a., Jessica Meier, p.g.a., Adam Goodman and Matt Skiena; and executive produced by David M. Bernstein, Ellen Goldsmith-Vein and Jeremy Bell. The film features the work of Yves Bélanger, director of photography; Ron Reiss, production designer; Joel Cox, David Cox, editors; Deborah Hopper, costume designer; Mark Mancina, original score; and Geoffrey Miclat, casting.
As previously announced, the world premiere of the documentary film Music By John Williams will open AFI Fest on October 23, the world premiere of Robert Zemeckis’ Here will be the Centerpiece Screening on October 25, and the world premiere of Wallace & Gromit: Vengeance Most Fowl will screen on the afternoon of October 27.
AFI Fest presented by Canva will take place October 23–27. The full festival lineup will be unveiled on October 1.
Changing OpenAI’s Nonprofit Structure Would Raise Questions and Heightened Scrutiny
The artificial intelligence maker OpenAI may face a costly and inconvenient reckoning with its nonprofit origins even as its valuation recently exploded to $157 billion.
Nonprofit tax experts have been closely watching OpenAI, the maker of ChatGPT, since last November when its board ousted and rehired CEO Sam Altman. Now, some believe the company may have reached — or exceeded — the limits of its corporate structure, under which it is organized as a nonprofit whose mission is to develop artificial intelligence to benefit "all of humanity" but with for-profit subsidiaries under its control.
Jill Horwitz, a professor in law and medicine at UCLA School of Law who has studied OpenAI, said that when two sides of a joint venture between a nonprofit and a for-profit come into conflict, the charitable purpose must always win out.
"It's the job of the board first, and then the regulators and the court, to ensure that the promise that was made to the public to pursue the charitable interest is kept," she said.
Altman recently confirmed that OpenAI is considering a corporate restructure but did not offer any specifics. A source told The Associated Press, however, that the company is looking at the possibility of turning OpenAI into a public benefit corporation. No final decision has been made by the board and the timing of the shift hasn't been determined, the source said.
In the event the nonprofit loses control of its subsidiaries, some experts think OpenAI may have to pay for the interests and assets that had belonged to the nonprofit. So far, most observers agree OpenAI has carefully orchestrated its relationships between its nonprofit and its various other corporate entities to try to avoid that.
However, they also see... Read More